Home > Income Statement > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Consolidated Net Profit

    Back to Income Statement
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

EMCURE PHARMACEUTICALS Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹681 Cr₹498 Cr₹532 Cr₹662 Cr₹392 Cr

What is the latest Consolidated Net Profit of EMCURE PHARMACEUTICALS ?

The latest Consolidated Net Profit ratio of EMCURE PHARMACEUTICALS is ₹681 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹681 Cr
Mar2024₹498 Cr
Mar2023₹532 Cr
Mar2022₹662 Cr
Mar2021₹392 Cr

How is Consolidated Net Profit of EMCURE PHARMACEUTICALS Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹681 Cr
36.76
Mar2024 ₹498 Cr
-6.36
Mar2023 ₹532 Cr
-19.66
Mar2022 ₹662 Cr
68.87
Mar2021 ₹392 Cr -

Compare Consolidated Net Profit of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹27,190.5 Cr -2.5% -5.7% 49.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹415,613.0 Cr 0.9% 6.2% 0.6% Stock Analytics
DIVIS LABORATORIES ₹166,047.0 Cr 1.8% 4.8% 6.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,926.0 Cr 1.3% 9.8% 37.7% Stock Analytics
DR REDDYS LABORATORIES ₹108,454.0 Cr 1.7% 5.8% 6.7% Stock Analytics
CIPLA ₹107,136.0 Cr -1.3% 0.9% -8.9% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

-2.5%

-5.7%

49.9%

SENSEX

0%

1.2%

9.7%


You may also like the below Video Courses